Hinge Health, Inc. HNGE
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 43.69M | 35.13M | 32.10M | -106.02M | -575.65M |
| Total Depreciation and Amortization | 461.00K | 473.00K | 523.00K | 564.00K | 543.00K |
| Total Amortization of Deferred Charges | 19.69M | 16.91M | 14.93M | 13.27M | 11.48M |
| Total Other Non-Cash Items | 22.22M | 12.73M | 17.67M | 140.55M | 594.09M |
| Change in Net Operating Assets | 15.36M | -22.16M | -1.32M | 34.04M | -10.23M |
| Cash from Operations | 101.41M | 43.08M | 63.89M | 82.40M | 20.23M |
| Capital Expenditure | -123.00K | -83.00K | -408.00K | -52.00K | -197.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.74M | 48.16M | -37.29M | -58.71M | 4.22M |
| Cash from Investing | 28.62M | 48.08M | -37.70M | -58.76M | 4.02M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.55M | 410.00K | 8.74M | 531.00K | 255.83M |
| Repurchase of Common Stock | -38.02M | -113.26M | -88.00M | 0.00 | -272.26M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -288.00K | 0.00 | -59.13M |
| Cash from Financing | -30.48M | -112.85M | -79.55M | 531.00K | -75.56M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.55M | -21.68M | -53.35M | 24.17M | -51.31M |